COAG (Hemab Therapeutics Holdings, Inc. Common Stock) Stock Analysis - Analyst Ratings
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of May 21, 2026, COAG trades at $26.47 with a market cap of $1.27B and a P/E ratio of 0.00. COAG moved +2.40% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $36.61. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate COAG?
The average price target is $0.00.
COAG Key Metrics
Key financial metrics for COAG
Metric
Value
Price
$26.47
Market Cap
$1.27B
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$36.61
52-Week Low
$23.00
Volume
206
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
COAG Analyst Consensus
COAG analyst coverage data. Average price target: $0.00.